Current pre-clinical drug safety evaluation methods remain costly, inefficient, and unreliable, with 80–90% of compounds ultimately failing in human trials — often due to poor predictive models and safety concerns. Scaffold-based 3D organ models offer a more promising and physiologically relevant
Last updated on: 02-10-2025 - 14:55
Contact: Jolanda van Hengel
Organisation: Ghent University (UGent), Ghent University hospital (UZ Gent), Interuniversitair Micro-Electronica Centrum (IMEC), University of Hasselt (UHasselt)
Status: Still in development
